The medical cannabis industry is one of the fastest-growing—and most complex—regulated markets in the United States.
While many states allow medical cannabis programs, federal law still creates uncertainty, resulting in a fragmented and constantly evolving regulatory landscape.
For companies operating in this space, success depends on one thing:
getting compliance right from the start—and sustaining it over time.
RQMIS helps you do exactly that.
Medical cannabis in the U.S. is governed by a mix of:
Each state has its own rules for cultivation, processing, distribution, and sale—and those rules change frequently.
At the same time:
The result? High risk of delays, rejections, and costly compliance gaps.
RQMIS brings structure to a fragmented system.
We combine deep expertise in medical devices, pharmaceuticals, and quality systems with a practical understanding of cannabis regulations—helping you build a compliant, scalable operation from day one.
We guide you through the complex process of obtaining and maintaining cannabis licenses.
Because licensing isn’t just paperwork—it’s a strategic process that determines your ability to operate.
Compliance starts with a strong foundation.
We help you build FDA- and GMP-aligned quality systems, including:
These systems ensure product safety, consistency, and scalability.
We ensure your products meet regulatory expectations before they reach the market.
Cannabis products must be safe, consistent, and traceable.
We help you implement systems to:
Compliance doesn’t stop at launch.
We support:
This ensures you remain compliant as regulations—and your business—evolve.
The cannabis industry is growing rapidly—but so are the risks.
Companies that succeed are the ones that:
RQMIS helps you do all three.
With RQMIS, you can:
In the cannabis industry, compliance isn’t optional—it’s your competitive advantage.
Contact RQMIS to build a compliant, scalable path to success in the U.S. medical cannabis market.